摘要
世界糖尿病患病人数逐年升高,中国糖尿病的患病率居于首位。糖尿病视网膜病变(diabetic retinopathy,DR)作为糖尿病的重要微血管并发症,已经成为当今工作年龄人群中主要的致盲眼病之一,对社会和家庭带来了极大的负担。近年来,多项基础及临床研究都在进行DR发病及治疗的探讨。美国眼科学会于2019年发布了最新版DR临床指南,该版指南对上一版本指南进行了补充及修订,对DR的定义、流行病学、分类、检查以及诊断治疗等方面进行了详细的介绍。本文将对2019版指南进行全面的解读,以期规范眼科医师对DR的认识、诊断和治疗,从而更好地减轻患者家庭和社会负担。
The numbers of population with diabetes have risen sharply worldwide.China has become a country with high incidence of diabetes.Diabetic retinopathy(DR),as a crucial microvascular complication of diabetes,has become one of the major ocular diseases causing blindness among the working age population,bringing tremendous burden to the society and families.Recently,increasing number of attentions has been paid to DR.Various basic and clinical studies have been performed to discuss the pathogenesis and treatment of DR.In the year 2019,the American Ophthalmological Association published a new version of Diabetic Retinopathy Preferred Practice Pattern,which introduced the definition,epidemiology,classification,examination,diagnosis and treatment of DR in great detail.This article will precede a comprehensive interpretation to this edition,hoping to standardize the understanding,diagnosis and treatment of DR,so as to better reduce the family and social burden of patients.
作者
李筱荣
杨千惠
Li Xiaorong;Yang Qianhui(Tianjin Key Laboratory of Retinal Functions and Diseases,Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science,Eye Institute and School of Optometry,Tianjin Medical University Eye Hospital,Tianjin 300384,China)
出处
《中华实验眼科杂志》
CAS
CSCD
北大核心
2020年第9期795-798,共4页
Chinese Journal Of Experimental Ophthalmology
关键词
糖尿病视网膜病变
临床指南
解读
Diabetic retinopathy
Preferred practice pattern
Interpretation